ID   ETCC
AC   CVCL_ZZ38
SY   Equine Transitional Cell Carcinoma
DR   Wikidata; Q102113798
RX   PubMed=558280;
RX   PubMed=4421147;
RX   PubMed=23594411;
CC   Virology: Susceptible to infection by equine herpesvirus type 3 (EHV-3) (PubMed=558280).
CC   Doubling time: 16 hours (PubMed=4421147).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
DI   NCIt; C173624; Horse transitional cell carcinoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
RX   PubMed=558280; DOI=10.1099/0022-1317-34-3-421;
RA   Allen G.P., Bryans J.T.;
RT   "Replication of equine herpesvirus type 3: kinetics of infectious
RT   particle formation and virus nucleic acid synthesis.";
RL   J. Gen. Virol. 34:421-430(1977).
//
RX   PubMed=4421147;
RA   Allen G.P., Bryans J.T.;
RT   "Studies of an established equine cell line derived from a
RT   transitional cell carcinoma.";
RL   Am. J. Vet. Res. 35:1153-1160(1974).
//
RX   PubMed=23594411; DOI=10.1292/jvms.12-0450;
RA   Oguma K., Ishida M., Maeda K., Sentsui H.;
RT   "Efficient propagation of equine viruses in a newly established equine
RT   cell line, FHK-Tcl3.1 cells.";
RL   J. Vet. Med. Sci. 75:1223-1225(2013).
//